Literature DB >> 10914964

Clinical and laboratory impact of coagulase-negative staphylococci bacteremia in preterm infants.

A Maayan-Metzger1, N Linder, D Marom, T Vishne, S Ashkenazi, L Sirota.   

Abstract

UNLABELLED: A retrospective evaluation of the clinical and laboratory impact of coagulase-negative staphylococci (CONS) bacteremia in preterm infants was carried out. The study population included all preterm infants (n = 31) in whom two or more blood cultures were positive for CONS within a period of 4 d, with negative blood cultures 1 wk before and 1 wk after the CONS bacteremia. Clinical manifestations and the results of laboratory tests 7 d before and after the positive blood cultures, and on the first day of sepsis, were recorded and compared. During CONS bacteremia, the infants demonstrated apnoea and bradycardia (88%) and a need for oxygen (59%) and ventilatory support (69%). Significant laboratory findings were leukopenia below 5,000 cells/mm3 (12%), leukocytosis above 30,000 cells/mm3 (39%), and thrombocytopenia below 150,000/mm3 (25%). These clinical and laboratory manifestations differed significantly during the bacteremia infection compared with the week before and after.
CONCLUSION: CONS bacteremia is a clinically significant infection in preterm infants, causing episodes of apnoea and bradycardia, and a need for ventilatory support.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914964     DOI: 10.1080/080352500750044016

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

Review 1.  Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

2.  Systemic inflammation associated with mechanical ventilation among extremely preterm infants.

Authors:  Carl L Bose; Matthew M Laughon; Elizabeth N Allred; T Michael O'Shea; Linda J Van Marter; Richard A Ehrenkranz; Raina N Fichorova; Alan Leviton
Journal:  Cytokine       Date:  2012-11-11       Impact factor: 3.861

3.  Persistent coagulase-negative staphylococci bacteremia in very-low-birth-weight infants.

Authors:  Nehama Linder; Adriana Hernandez; Limor Amit; Gil Klinger; Shai Ashkenazi; Itzhak Levy
Journal:  Eur J Pediatr       Date:  2011-01-08       Impact factor: 3.183

4.  Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.

Authors:  Luciana Rodriguez-Guerineau; María Dolors Salvia-Roigés; Marisol León-Lozano; José Manuel Rodríguez-Miguélez; Josep Figueras-Aloy
Journal:  Eur J Pediatr       Date:  2013-01-18       Impact factor: 3.183

5.  Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.

Authors:  Nehama Linder; Daniel Lubin; Adriana Hernandez; Limor Amit; Shai Ashkenazi
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

6.  Coagulase-negative staphylococci strains resistant to oxacillin isolated from neonatal blood cultures.

Authors:  Valéria Cataneli Pereira; Maria de Lourdes Ribeiro de Souza da Cunha
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-11       Impact factor: 2.743

7.  Thrombocytopenia related neonatal outcome in preterms.

Authors:  Lea Bonifacio; Anna Petrova; Shakuntala Nanjundaswamy; Rajeev Mehta
Journal:  Indian J Pediatr       Date:  2007-03       Impact factor: 5.319

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.